Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 27
- 13F valueReported value at the end of Q2 2026
- $2.75M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding DARE, Q2 2026
No superinvestor reported holding DARE at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Dare Bioscience, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Dare Bioscience, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Dare Bioscience, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 640,877 | $1.35M | 0.00% | +178,572+38.6% | Added |
| Geode Capital Management, LLC | 140,093 | $295.6K | 0.00% | −37,746−21.2% | Reduced |
| US Bancorp | 120,920 | $255.1K | 0.00% | +29,550+32.3% | Added |
| Vanguard Fiduciary Trust Co | 91,269 | $192.6K | 0.00% | +25,331+38.4% | Added |
| BlackRock, Inc. | 64,248 | $135.6K | 0.00% | +47,277+278.6% | Added |
| State Street Corp | 47,415 | $100.0K | 0.00% | +23,900+101.6% | Added |
| Jane Street Group, LLC | 36,092 | $76.2K | 0.00% | +36,092 | New |
| Northern Trust Corp | 34,209 | $72.2K | 0.00% | +18,778+121.7% | Added |
| HRT Financial LP | 22,430 | $47.0K | 0.00% | +22,430 | New |
| Virtu Financial LLC | 15,803 | $33.0K | 0.00% | +15,803 | New |